Autoimmune Diseases (Lupus / Rheumatoid Arthritis / Gout) C&P Exam Prep

Antinuclear Antibody (ANA) Titer

What it measures: Presence and concentration of antibodies directed against the cell nucleus; a hallmark serologic marker for SLE and other connective tissue diseases.

What to expect: Blood draw; examiner will review existing results or order new labs. Titers -1:80 are considered positive. The pattern (speckled, homogeneous, nucleolar) is also recorded.

Pain considerations: This is a blood draw; bring documentation of any prior results to avoid repeat testing delays.

Anti-dsDNA (Anti-Double-Stranded DNA) Antibody

What it measures: Antibodies highly specific for SLE; elevated levels correlate with disease activity and renal involvement (lupus nephritis).

What to expect: Blood draw; examiner reviews existing results. Elevated anti-dsDNA is one of the 11 ACR/SLICC classification criteria for SLE.

Pain considerations: No pain involved in blood draw; ensure results from treating rheumatologist are brought to the exam.

Complement Components C3 and C4

What it measures: Serum complement proteins; low levels indicate complement consumption from immune complex deposition, a sign of active lupus - particularly lupus nephritis.

What to expect: Blood draw; examiner reviews existing results. Low C3/C4 with elevated anti-dsDNA is a classic triad indicating active SLE.

Pain considerations: Standard blood draw; no additional pain considerations.

Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP)

What it measures: Inflammatory markers that are elevated during active autoimmune disease and flares.

What to expect: Blood draw; examiner reviews existing results. Elevated ESR and CRP support ongoing inflammatory process.

Pain considerations: Standard blood draw.

Complete Blood Count (CBC) with Differential

What it measures: Evaluates for hematologic manifestations of autoimmune disease: hemolytic anemia (low hemoglobin/hematocrit), leukopenia/lymphopenia (<1,500 cells/-L), thrombocytopenia.

What to expect: Blood draw; examiner reviews hemoglobin, hematocrit, RBC count, WBC count with differential, and platelet count.

Pain considerations: Standard blood draw; advise examiner if you bruise easily due to thrombocytopenia.

Urinalysis with Microscopy

What it measures: Screens for renal involvement: proteinuria, hematuria, red blood cell casts (hyaline, granular casts), glucose in urine. Critical for documenting lupus nephritis.

What to expect: Urine sample collection; examiner reviews protein levels, blood in urine, specific gravity, and microscopic findings (casts, RBCs).

Pain considerations: Urine collection is non-invasive; mention if frequent urination or dysuria are symptoms you experience.

Renal Function Panel (Creatinine, BUN, eGFR)

What it measures: Assesses kidney function; elevated creatinine and BUN with reduced eGFR indicate renal impairment from lupus nephritis or other autoimmune renal disease.

What to expect: Blood draw; examiner reviews creatinine level, BUN, and calculated eGFR.

Pain considerations: Standard blood draw.

Joint Range of Motion (ROM) Assessment

What it measures: For conditions with articular involvement (RA, lupus arthritis, psoriatic arthritis): measures active and passive ROM of affected joints, weight-bearing vs. non-weight-bearing positions per Correia requirements.

What to expect: Physical examination of affected joints. Examiner may use a goniometer to measure degrees of motion. Testing includes active ROM (you move the joint), passive ROM (examiner moves it), and assessment of pain, swelling, tenderness, and deformity.

Pain considerations: Inform the examiner of pain (on a 0-10 scale) at the start of movement, throughout the arc, and at end-range. Mention any fatigue, weakness, or incoordination in the affected joints.

100%

Active process with constitutional manifestations associated with active joint involvement or other organ or body system manifestations resulting in severe impairment of health.

From 38 CFR: Under DC 5002, 100% is assigned when the active process results in severe impairment of health. Per M21-1, active multi-joint arthritis with constitutional manifestations meeting this threshold warrants 100%. Note: The active process rating is NOT combined with residual ratings for limitation of motion, ankylosis, or DC 5003 - the higher evaluation is assigned instead.

60%

Active process with constitutional manifestations associated with active joint involvement or other organ or body system manifestations resulting in consideration of total disability.

From 38 CFR: DC 5002 at 60% reflects consideration of total disability without meeting the full severity threshold for 100%. Multi-joint arthritis as an active process with moderate organ involvement and constitutional manifestations. The active process rating is NOT combined with residual ROM or ankylosis ratings - the higher evaluation is used.

40%

Active process with constitutional manifestations associated with active joint involvement or other organ or body system manifestations with moderate impairment of health.

From 38 CFR: DC 5002 at 40% reflects moderate impairment of health from an active autoimmune process. Active multi-joint arthritis with constitutional manifestations and moderate functional impact. Per M21-1, this includes rheumatoid arthritis and psoriatic arthritis as active processes affecting 2 or more joints.

20%

Active process with constitutional manifestations associated with active joint involvement or other organ or body system manifestations with mild impairment of health, or when on continuous medication.

From 38 CFR: DC 5002 at 20% is the minimum compensable rating for multi-joint autoimmune arthritis as an active process. Even when controlled with continuous medication, an active process with constitutional manifestations in 2 or more joints warrants at least 20%. Note: Per DC 5002, Note 3, the active process rating is never combined with residual ratings for LOM or ankylosis; the higher evaluation controls.

Constitutional Symptoms (Fatigue, Fever, Weight Loss)

How to describe it: Describe fatigue using specific functional terms: 'I can only stand or walk for 20 minutes before needing to rest,' 'I require a 2-hour nap every afternoon,' or 'My fatigue is so severe that I cannot hold a full-time job.' Quantify fever episodes: frequency, duration, temperature, and whether they required medical treatment. Note any weight loss with the amount and timeframe.

Example: On my worst days, I cannot get out of bed until noon due to exhaustion. I have a low-grade fever of 99.8-F that comes and goes for weeks at a time. I have lost 15 pounds over the past 6 months without trying because I have no appetite and feel too ill to eat properly. Even a shower exhausts me to the point I need to sit down afterward.

Examiner listens for: The examiner is assessing whether constitutional manifestations are present alongside joint involvement - this is required for any compensable rating under DC 5002. They are specifically documenting: the presence and severity of fatigue, recurrent fever, weight loss, and how these symptoms interface with the active joint or organ system disease process.

Avoid: Do not say 'I'm a little tired' when you mean you cannot function normally due to fatigue. Do not say 'I've had some fevers' without giving frequency, duration, and severity. Avoid minimizing weight loss - document the amount and timeframe precisely.

Joint Pain, Swelling, and Morning Stiffness

How to describe it: Name every affected joint specifically (bilateral wrists, MCP joints, PIPs, knees, ankles). Describe pain using a 0-10 scale for both typical and worst days. Quantify morning stiffness in minutes - morning stiffness lasting more than 1 hour is clinically significant for RA. Describe swelling: Is it visible? Does it limit grip strength, walking, or fine motor tasks?

Example: On my worst days, every joint in both hands and wrists is swollen and so painful I cannot open a jar, button a shirt, or type on a keyboard. My knees are so stiff in the morning that I have to walk with a limp for the first 2 hours of the day. The pain is a 9 out of 10 and no amount of pain medication fully controls it. I have dropped objects because my grip is so weak.

Examiner listens for: The examiner is documenting all affected joints for the DBQ field that asks for joint listing, plus DeLuca factors: pain with use, fatigue, weakness, incoordination, and flare-up impact. They need 2 or more joints actively involved for DC 5002 applicability. Morning stiffness duration, pain throughout arc of motion (not just end-range), and functional limitations all feed into severity assessment.

Avoid: Do not only mention your worst joint - list every affected joint. Do not say pain is controlled by medication without noting the medication burden required to achieve that control. Do not omit morning stiffness duration - it is a key clinical indicator for inflammatory arthritis severity.

Skin Manifestations (Malar Rash, Discoid Lesions, Oral Ulcers, Alopecia)

How to describe it: Describe skin involvement by location, frequency, appearance, and duration. For malar rash: 'Butterfly rash across my cheeks and nose that appears with sun exposure or during flares, lasting 1-3 weeks.' For oral ulcers: 'Painful mouth sores that appear during flares making eating and speaking painful.' For hair loss: 'I lost significant hair during my last flare, leaving noticeable bald patches on my scalp.' Specify whether lesions scar.

Example: During my last major flare, the butterfly rash across my face was so inflamed and painful that I could not bear to go outside or be near windows. I had multiple painful ulcers inside my mouth that made eating anything other than soft foods impossible for two weeks. I lost a golf-ball-sized patch of hair from my scalp that left a permanent bald area. The skin on my fingers cracked and bled.

Examiner listens for: The DBQ has specific checkboxes for malar rash, discoid lupus, subacute cutaneous lupus, oral ulcers/scaling at lips, scalp with scarring alopecia, hands, feet, chin, nose, and ears. Accurate and detailed skin manifestation reporting ensures all relevant DBQ boxes are checked, directly affecting the documented severity of the active disease process.

Avoid: Do not fail to mention skin symptoms if they are part of your condition. Do not describe rashes as 'just cosmetic' - they are a documented ACR criterion for SLE and a DBQ-specific manifestation. Do not forget to mention if rashes are photosensitive, as this is also an ACR criterion.

Renal Symptoms (Kidney Involvement)

How to describe it: Describe any symptoms of kidney involvement: foamy or frothy urine (indicating protein), blood in urine (red or cola-colored), leg or ankle swelling (edema from low albumin), high blood pressure related to kidney disease, reduced urine output, or fatigue worsened by anemia from kidney disease. Reference specific lab values if known.

Example: My urine became so foamy during my last flare that it looked like it had soap in it, and my ankles swelled so much that I could not wear shoes. My blood pressure spiked to 160/100 and required emergency treatment. My rheumatologist told me my protein in the 24-hour urine test was 1.2 grams, which indicated my kidneys were being affected by lupus.

Examiner listens for: The examiner is documenting renal manifestations including glomerulonephritis, membranoproliferative glomerulonephritis, proteinuria, edema, and hypertension. Renal involvement significantly affects overall disease severity rating and may trigger a separate renal DBQ. The examiner will review urinalysis, creatinine, BUN, and eGFR results.

Avoid: Do not omit kidney-related symptoms even if your kidneys seem 'okay now' - document the history of prior renal involvement. Do not fail to bring lab results showing proteinuria or reduced eGFR - these are critical for the DBQ.

Cardiovascular and Pulmonary Symptoms

How to describe it: Describe chest pain (sharp, pleuritic pain worsened by breathing suggests pleuritis), shortness of breath at rest or with minimal exertion, heart palpitations, leg swelling, or diagnosis of pericarditis, pleuritis, or pulmonary hypertension. Note any hospitalizations for these complications and any cardiac or pulmonary testing (echocardiogram, chest X-ray, CT, pulmonary function tests).

Example: Last year I was hospitalized for pericarditis - I had severe sharp chest pain that was worse when I lay flat and better when I leaned forward. I was short of breath walking from my bedroom to the bathroom. My echocardiogram showed a pericardial effusion. I also have recurrent pleuritis that causes stabbing pain with every breath during flares.

Examiner listens for: The examiner specifically checks for: pericardial effusion, myocarditis, coronary artery vasculitis, Libman-Sacks endocarditis, valvular involvement, pulmonary emboli, pulmonary hypertension, shrinking lung syndrome, and recurrent pleuritis. These are severe organ manifestations that significantly elevate the rating consideration under DC 5002.

Avoid: Do not minimize chest pain as 'just stress' - report it accurately with clinical context. Do not omit prior hospitalizations for cardiac or pulmonary complications from your condition.

Medication Burden and Treatment History

How to describe it: List every medication with the name, dose, and how long you have been taking it. Distinguish between: oral corticosteroids (prednisone - dose and duration matters critically), immunosuppressants (methotrexate, azathioprine, mycophenolate, cyclophosphamide, belimumab, rituximab), antimalarials (hydroxychloroquine), and topical treatments. Note side effects: weight gain, bone loss, infections, mood changes, blood sugar elevation, cataracts.

Example: I have been on prednisone 20mg daily for the past 8 months continuously because every time my doctor tries to taper below 10mg, my disease flares severely. I also take mycophenolate mofetil 2,000mg daily. The prednisone has caused me to gain 30 pounds, develop pre-diabetes, and I have been told I have early osteoporosis. I am on calcium and vitamin D supplements because of the bone loss.

Examiner listens for: The DBQ has specific fields for oral corticosteroids (with duration), immunosuppressive agents including retinoids, topical corticosteroids, and other oral/topical autoimmune medications. Long-term continuous corticosteroid or immunosuppressive therapy is itself a marker of disease severity and contributes to documenting the active process. Side effects from medications are separately ratable conditions.

Avoid: Do not fail to disclose all medications including over-the-counter NSAIDs and supplements used for the condition. Do not understate the duration of corticosteroid use - continuous vs. intermittent use has different implications for the rating. Do not omit biologic agents like belimumab or rituximab - these are strong indicators of severe, refractory disease.

Flares, Exacerbations, and Disease Course

How to describe it: Describe flare frequency: 'I have approximately 4-6 significant flares per year, each lasting 2-4 weeks.' Describe what triggers flares (sun exposure, infections, stress, missed medication), how severe they are, how long they last, and whether they require emergency or urgent care, hospitalization, or medication changes. Note the time between flares and whether you have true remission periods.

Example: My worst flare lasted 3 months last year and required two hospitalizations. During that time, I could not work, drive, or care for myself. I needed help from family members to prepare meals and get dressed. My doctor increased my prednisone to 60mg and added cyclophosphamide. I have not had a true remission in over two years - I am always experiencing at least some level of disease activity.

Examiner listens for: The examiner documents exacerbation history, frequency, and severity in the DBQ. The frequency and severity of flares directly correlate with whether the active process meets the 20%, 40%, 60%, or 100% threshold. Exacerbations requiring hospitalization or major medication escalation are strong evidence for higher rating levels.

Avoid: Do not describe your condition only on an average day - the VA rates based on your worst typical day. Do not say you 'manage fine' if you require significant medication, lifestyle modifications, and periodic hospitalization. Do not omit prior hospitalizations or ER visits related to the condition.

Functional Impact on Work and Daily Activities

How to describe it: Describe specifically how the condition affects your ability to work, perform household tasks, and engage in social or recreational activities. Use concrete examples: 'I cannot stand for more than 20 minutes,' 'I miss 3-5 days of work per month during flares,' 'I had to stop working entirely due to my condition,' 'I cannot lift my grandchildren.' Describe adaptive equipment or assistance you need.

Example: During flares, I am completely bedridden for days at a time. I have missed so many days of work that I was put on medical leave and eventually had to resign. I cannot cook, clean, or do laundry on bad days. I rely on my spouse to help me dress, bathe, and manage my medications. Even on good days, I tire easily and cannot commit to regular activities because I never know when the next flare will hit.

Examiner listens for: The DBQ has a specific field asking about the impact of the veteran's autoimmune disease on daily activities and occupational functioning. This is directly tied to the 'severe impairment of health' language at the 100% level and 'consideration of total disability' at 60%. Functional impact evidence is critical for accurate rating.

Avoid: Do not say 'I get by' when you mean you have dramatically reduced your activity level and given up meaningful activities. Do not omit occupational impact - lost jobs, reduced hours, missed days, and accommodations all matter. Do not fail to mention if you are receiving SSDI, because this demonstrates functional impairment recognized by another federal agency.